LYMPHOHISTIOCYTOSIS

Course overview

HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH) IS A LIFE-THREATENING, HYPER-INFLAMMATORY DISORDER AFFECTING BOTH NEWBORNS AND ADULTS ALIKE. THE DISEASE IS CHARACTERIZED BY DYSREGULATED IMMUNE ACTIVITY RESULTING IN MALIGNANT INFLAMMATION AND MULTI-ORGAN FAILURE. THIS ACTIVITY REVIEWS THE EVALUATION AND TREATMENT OF HLH AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN EVALUATING AND TREATING PATIENTS WITH THIS CONDITION.